Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYHematology, Transfusion and Cell Therapy

TWO CASES OF HEMOGLOBINOPATHY SC-LIKE RETINOPATHY ASSOCIATED WITH COINHERITANCE OF PIEZO1 VARIANTS AND SICKLE CELL TRAIT

  1. 1Divisão de Hematologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil
  2. 2Centro Integrado de Doenças Genéticas e Raras, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil
  3. 3Laboratório Clínico, Hospital Israelita Albert Einstein (HIAE), São Paulo, SP, Brazil

Abstract

Background: Sickle cell trait is a benign condition, which in the absence of other beta-hemoglobin variants is considered to not cause disease. However, variants in other genes involved in red blood cell (RBC) deformability and hydration content could lead to abnormal cell physiology, manifesting as clinical complications normally attributed to sickle cell disease. Here, we report two cases of unrelated patients with sickle cell trait (heterozygous variant HBB:NM_000518.5:c.20A>T) and features resembling Hemoglobinopathy SC disease, in the absence of other HBB variants. Cases: Two men developed proliferative retinopathy at a young age, without traditional risk factors. In the work-up of the manifestation, both were shown to have compensated hemolysis with stomatocytes in peripheral blood, and iron overload in the absence of transfusion. Moreover, both patients presented splenomegaly and gallstones. Further investigation revealed HbAS pattern on electrophoresis and normal osmotic fragility test. A Laser-assisted Optical Rotational Cell Analyzer (LORRCA) test was performed, with RBC from both patients presenting a similar behavior, typical of dehydrated stomatocytosis (higher deformability at hyposmolar medium and decreased deformability at isosmolar and hyperosmolar media). Moreover, these LORRCA results, when compared to HbAS RBC, were more markedly different from that of HbAA controls, indicating the presence of an additional RBC factor interfering with their physiology. Given these results, both patients were investigated for mutations in the PIEZO1 gene. Patient 1 had PIEZO1 sequenced as part of a previously published work (Oliveira, 2020) with a heterozygous variant c.6041C>T:p.(Thr2014Ile), considered likely pathogenic. Importantly, his mother displayed the variant, but not HbAS, and presented features of dehydrated stomatocytosis, but did not have vascular complications. Patient 2 went through whole exome sequencing at the Centro Integrado de Doenças Genéticas e Raras (CIGEN), leading to the identification of the variant PIEZO1:c.5914T>A:p.(Phe1972Ile), deemed of uncertain significance. Discussion: The cases presented here highlight the interplay of variants in two different genes leading to relevant clinical phenotypes which cannot be fully explained by the variants of each gene separately. Sickle cell trait is a benign disorder, but with relatively unexplored genetic modifiers that might lead to clinical manifestations. Conversely, dehydrated stomatocytosis, most commonly caused by gain of function (GoF) mutations in PIEZO1, can have a wide spectrum of hemolysis and iron overload, but small-vessel occlusion phenomena, like proliferative retinopathy, is not usually reported. Based on the clinical manifestations presented by the cases reported here, together with the functional and molecular studies, we propose that the combination of PIEZO1 GoF variants and sickle cell trait might lead to a retinopathy resembling that of Hemoglobinopathy SC disease. The rational behind this presentation is that the RBC dehydration, as a consequence of PIEZO1 mutations in hereditary xerocytosis, would lead to increased HbS concentration in RBC. This phenomenon would mimic the dehydration provoked by the presence of hemoglobin C, which leads to chronic hemolysis and increased blood viscosity. Finally, and in line with this rationale, both patients responded well to regular therapeutic phlebotomies as usually done in the management of HbSC disease.

Related

  1. 40 Hz vibrotactile stimulation ameliorates amyloid pathology and cognitive deficits in 5xFAD mice and is associated with alterations in Piezo1, ERK, and GSK-3β/p65 signaling
    Myeong-Hyun Nam, Hee-Jung Park, Hee-Yeon Lee +7
    NeurotherapeuticsPeer-reviewedCC BYFull textPhysiologyDOAJ
  2. Population Genetic Screening of Hemoglobinopathy Carrier Prevalence Compared to Medical Records
    Nathaniel E. Miller, Kurt Vergunst, Konstantinos N. Lazaridis +9
    Mayo Clinic proceedingsPeer-reviewedLicence not statedFull textHuman geneticsPMC
  3. Systematic validation of zucker diabetic-sprague dawley male rats as a model for type 2 diabetes-associated diabetic retinopathy
    Ge Zhang, Wei Shi, Siya Zhang +4
    Scientific ReportsPeer-reviewedCC BY 4.0Full textGeneral medicineCrossref
  4. Circulating and extracellular vesicle-associated non-coding RNAs in diabetic retinopathy: a stage-aware framework for network-informed biomarker panels
    Ji-Won Yu, Myung-Ji Choi, Dong Cheol Lee +1
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefPMC
  5. Identification and mechanistic investigation of novel biomarkers for diabetic retinopathy through hypoxia- and cuproptosis-associated gene analysis
    Rong Feng, Xia Wang, Xiaodong Li +4
    PLOS OnePeer-reviewedCC BY 4.0Full textCell biologyImmunologyPLOS
BibTeX
@article{dossantos2026cases,
  title = {{TWO CASES OF HEMOGLOBINOPATHY SC-LIKE RETINOPATHY ASSOCIATED WITH COINHERITANCE OF PIEZO1 VARIANTS AND SICKLE CELL TRAIT}},
  author = {Joao Conrado Khouri DOS-SANTOS and Liliana Mitie SUGANUMA and Bruno Guimaraes MARCARINI and Priscila Meira OLIVEIRA and Roberta SITNIK and Iara Keiko YOKOMIZO and Afonso Celso CARDOSO and Vanderson ROCHA and Paulo Augusto SILVEIRA and Guilherme Henrique Hencklain FONSECA and Sandra GUALANDRO},
  journal = {Hematology, Transfusion and Cell Therapy},
  year = {2026},
  month = oct,
  doi = {10.1016/j.htct.2026.106708},
  url = {https://doi.org/10.1016/j.htct.2026.106708},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - TWO CASES OF HEMOGLOBINOPATHY SC-LIKE RETINOPATHY ASSOCIATED WITH COINHERITANCE OF PIEZO1 VARIANTS AND SICKLE CELL TRAIT
AU  - Joao Conrado Khouri DOS-SANTOS
AU  - Liliana Mitie SUGANUMA
AU  - Bruno Guimaraes MARCARINI
AU  - Priscila Meira OLIVEIRA
AU  - Roberta SITNIK
AU  - Iara Keiko YOKOMIZO
AU  - Afonso Celso CARDOSO
AU  - Vanderson ROCHA
AU  - Paulo Augusto SILVEIRA
AU  - Guilherme Henrique Hencklain FONSECA
AU  - Sandra GUALANDRO
PY  - 2026
DA  - 2026/10/23
JO  - Hematology, Transfusion and Cell Therapy
DO  - 10.1016/j.htct.2026.106708
UR  - https://doi.org/10.1016/j.htct.2026.106708
AB  - Background: Sickle cell trait is a benign condition, which in the absence of other beta-hemoglobin variants is considered to not cause disease. However, variants in other genes involved in red blood cell (RBC) deformability and hydration content could lead to abnormal cell physiology, manifesting as clinical complications normally attributed to sickle cell disease. Here, we report two cases of unrelated patients with sickle cell trait (heterozygous variant HBB:NM_000518.5:c.20A>T) and features resembling Hemoglobinopathy SC disease, in the absence of other HBB variants. Cases: Two men developed proliferative retinopathy at a young age, without traditional risk factors. In the work-up of the manifestation, both were shown to have compensated hemolysis with stomatocytes in peripheral blood, and iron overload in the absence of transfusion. Moreover, both patients presented splenomegaly and gallstones. Further investigation revealed HbAS pattern on electrophoresis and normal osmotic fragility test. A Laser-assisted Optical Rotational Cell Analyzer (LORRCA) test was performed, with RBC from both patients presenting a similar behavior, typical of dehydrated stomatocytosis (higher deformability at hyposmolar medium and decreased deformability at isosmolar and hyperosmolar media). Moreover, these LORRCA results, when compared to HbAS RBC, were more markedly different from that of HbAA controls, indicating the presence of an additional RBC factor interfering with their physiology. Given these results, both patients were investigated for mutations in the PIEZO1 gene. Patient 1 had PIEZO1 sequenced as part of a previously published work (Oliveira, 2020) with a heterozygous variant c.6041C>T:p.(Thr2014Ile), considered likely pathogenic. Importantly, his mother displayed the variant, but not HbAS, and presented features of dehydrated stomatocytosis, but did not have vascular complications. Patient 2 went through whole exome sequencing at the Centro Integrado de Doenças Genéticas e Raras (CIGEN), leading to the identification of the variant PIEZO1:c.5914T>A:p.(Phe1972Ile), deemed of uncertain significance. Discussion: The cases presented here highlight the interplay of variants in two different genes leading to relevant clinical phenotypes which cannot be fully explained by the variants of each gene separately. Sickle cell trait is a benign disorder, but with relatively unexplored genetic modifiers that might lead to clinical manifestations. Conversely, dehydrated stomatocytosis, most commonly caused by gain of function (GoF) mutations in PIEZO1, can have a wide spectrum of hemolysis and iron overload, but small-vessel occlusion phenomena, like proliferative retinopathy, is not usually reported. Based on the clinical manifestations presented by the cases reported here, together with the functional and molecular studies, we propose that the combination of PIEZO1 GoF variants and sickle cell trait might lead to a retinopathy resembling that of Hemoglobinopathy SC disease. The rational behind this presentation is that the RBC dehydration, as a consequence of PIEZO1 mutations in hereditary xerocytosis, would lead to increased HbS concentration in RBC. This phenomenon would mimic the dehydration provoked by the presence of hemoglobin C, which leads to chronic hemolysis and increased blood viscosity. Finally, and in line with this rationale, both patients responded well to regular therapeutic phlebotomies as usually done in the management of HbSC disease.
SN  - 2531-1379
SN  - 2531-1387
ER  -